Myeloid Malignancy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Myeloid Malignancy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Myeloid Malignancy Program Today - Breaking & Trending Today

Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides ...

Published: March 15, 2022

BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the mutant tumor suppressor protein,

Source: kentuckytoday.com

Related Topics:

United StatesGregorya KorbelScottm CoianteCompany PhaseSolid Tumor ProgramEuropean CommissionDrug AdministrationAprea Therapeutics IncExchange CommissionMyeloid Malignancy ProgramLymphoid Malignancy ProgramSecurities ExchangeOperations UpdateAprea TherapeuticsOrphan DrugFast TrackSecurities ActSecurities Exchange ActVice PresidentChief FinancialChief BusinessConsolidated StatementsMonths Ended DecemberEnded December